Epidiolex Placed In Controlled Substances Act
October 1, 2018
FDA-Approved Drug Epidiolex Placed in Schedule V of Controlled Substances Act The Department of Justice and Drug Enforcement Administration (DEA) today announced that Epidiolex, the newly approved medication by the Food & Drug Administration (FDA), is being placed in schedule V of the Controlled Substances Act (CSA), the least restrictive schedule of the CSA. In […]